The CRISPR technology has partially restored vision to people with inherited blindness.
Scientists have presented the results of the first phase of clinical trials involving 14 people with inherited blindness, specifically Leber congenital amaurosis. Significant improvements in vision parameters have been observed with the application of CRISPR gene editing technology. Leber congenital amaurosis is characterized by a mutation in the CEP290 gene, resulting in severe vision loss,…